Assessment and management of hypoglycemia in children and adolescents with diabetes
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
This article is a chapter in the ISPAD Clinical Practice Consensus Guidelines 2014 Compendium.The complete set of guidelines can be found for free download at www.ispad.org.The evidence grading system used in the ISPAD Guidelines is the same as that used by the American Diabetes Association.See page 3 (the Introduction in Pediatric Diabetes 2014; 15 (Suppl.20): 1-3).symptoms (i.e., hypoglycemia unawareness).• Blood glucose goals may need to be adjusted upward in patients with recurrent hypoglycemia and/or hypoglycemia unawareness (B).• If unexplained hypoglycemia is frequent, evaluation for unrecognized celiac and Addison's disease should be considered (E).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 2×
“In the adult population, severe hypoglycemia is defined as an event requiring assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions (13).”
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Ly, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411 · cited 2×
“A recent randomized controlled trial (80) has been the first to show a reduction in severe hypoglycemia, defined as hypoglycemic coma or convulsion, with the use of sensor-augmented pump therapy with low glucose insulin suspension.”
Self-citationDavis, E. A., Keating, B., Byrne, G. C., Russell, M., & Jones, T. W. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.22 · Cited by 273
Self-citationCengiz, E., Xing, D., Wong, J. C., Wolfsdorf, J. I., Haymond, M. W., Rewers, A., Shanmugham, S., Tamborlane, W. V., Willi, S. M., Seiple, D. L., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12030 · Cited by 243 · cited 5×
“aDepartment of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA; bSchool of Paediatrics and Child Health, The University of Western Australia, Perth, WA, Australia; cBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medic…”
InfluentialSelf-citationSmart, C. E. M., Evans, M., O’Connell, S. M., McElduff, P., Lopez, P. E., Jones, T. W., Davis, E. A., & King, B. R. (2013) · Diabetes Care · doi:10.2337/dc13-1195 · Cited by 240 · cited 1×
“Insulin action profile What was the timing and duration of insulin administration? What is the peak insulin action? Consider rapid-acting and long-acting insulin analogs for multiple daily injections for more physiological insulin delivery Consider insulin pump therapy (89) Consider dual-wave insulin bolus with low gl…”
Self-citationPerantie, D. C., Lim, A., Wu, J., Weaver, P., Warren, S. L., Sadler, M., White, N. H., & Hershey, T. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00274.x · Cited by 237
Tanenberg, R. J., Newton, C. A., & Drake, A. J. (2010) · Endocrine Practice · doi:10.4158/ep09260.cr · Cited by 225
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-2081 · Cited by 180
Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., Gage, V., Caswell, K., Wilkinson, J., Cameron, F., Lee, H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2303 · Cited by 169 · cited 1×
“Predictive low glucose insulin suspend algorithms based on continuous glucose measurements have been developed and tested in a number of clinical trials (81, 82).”
Beregszàszi, M., Tubiana-Rufi, N., Benali, K., Noël, M., Bloch, J., & Czernichow, P. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70121-5 · Cited by 122
Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Wiethop, B. V., & Cryer, P. E. (1993) · Diabetes Care · doi:10.2337/diacare.16.8.1131 · Cited by 99
Treatment of Insulin Reactions in Diabetics
Brodows, R. G. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350240024032 · Cited by 91
Independent Effects of Youth and Poor Diabetes Control on Responses to Hypoglycemia in Children
Jones, T. W., Boulware, S. D., Kraemer, D. T., Caprio, S., Sherwin, R. S., & Tamborlane, W. V. (1991) · Diabetes · doi:10.2337/diab.40.3.358 · Cited by 85
Self-citationKalergis, M., Schiffrin, A., Gougeon, R., Jones, P. J. H., & Yale, J.-F. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.9 · Cited by 82 · cited 1×
“Studies of dietary intervention to prevent nocturnal hypoglycemia in adults with type 1 diabetes have found that a bedtime snack containing carbohydrate and protein offers some protection from nocturnal hypoglycemia, compared with carbohydrates alone (50).”
Ly, T. T., Hewitt, J., Davey, R. J., Lim, E. M., Davis, E. A., & Jones, T. W. (2011) · Diabetes Care · doi:10.2337/dc10-1042 · Cited by 81 · cited 2×
“Lack of hypoglycemic symptoms or hypoglycemia unawareness At what glucose level do you start to recognize hypoglycemia? What types of symptoms do you have? Consider increased monitoring of blood glucose levels Consider the use of real-time continuous glucose monitoring together with adjustment of glucose targets to av…”
Self-citationKaufman, F. R., Halvorson, M., & Kaufman, N. D. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01192-7 · Cited by 50
Bioactivity of Instant Glucose: Failure of Absorption Through Oral Mucosa
Gunning, R. R. (1978) · JAMA · doi:10.1001/jama.1978.03290150057025 · cited 1×
“was no buccal absorption of glucose (26).”
Cited by
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
Japanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Diabetology International · doi:10.1007/s13340-018-0345-3 · Cited by 319
Harris, D. L., Weston, P. J., Signal, M., Chase, J. G., & Harding, J. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61645-1 · Cited by 302
Outcome measures for artificial pancreas clinical trials: a consensus report
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., DeVries, J. H., Doyle, F. J., Griffen, S. C., Haidar, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2716 · Cited by 211
Self-citationVan Name, M. A., Hilliard, M. E., Boyle, C. T., Miller, K. M., DeSalvo, D. J., Anderson, B. J., Laffel, L. M., Woerner, S. E., DiMeglio, L. A., & Tamborlane, W. V. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12525 · Cited by 139
Metadata
- Authors
- Ly, T. T., Maahs, D. M., Rewers, A., Dunger, D., Oduwole, A., & Jones, T. W.
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2014-07-12
- Volume
- 15
- Issue
- S20
- Pages
- 180-192
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W2916931956
- Cited by
- 151
- References
- 23
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.